VBC103: An innovative Trop2/Nectin4 targeted bispecific antibody drug conjugate (ADC) in bladder urothelial carcinoma (UC), triple-negative breast cancer (TNBC) and beyond

被引：0
|
作者：
Wang, Wei
Li, Jing
Guan, Lingyu
Xu, Man
Yin, Qun
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB448
引用
收藏
页数：3
相关论文
共 21 条
  • [1] Development of Triple-negative breast cancer (TNBC) syngeneic models and TROP2-directed antibody-drug conjugate (ADC) surrogate to model therapeutic combinations
    Chou, Chih-Chien
    Kardos, Jordan
    Yang, Becky
    Orf, Jessica
    Dave, Rutwij
    Lai, Yurong
    Lee, Chingwei V.
    Papalia, Giuseppe A.
    Boyd, Kelli
    Diehl, Lauri
    Scholler, Nathalie
    CANCER RESEARCH, 2023, 83 (05)
  • [2] Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates
    Kaboli, Parham Jabbarzadeh
    Shabani, Shima
    Sharma, Sagar
    Nasr, Minoo Partovi
    Yamaguchi, Hirohito
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04): : 1671 - 1685
  • [3] Discovery of BCG033, a novel anti-PTK7 x TROP2 bispecific antibody-drug conjugate with promising efficacy against triple-negative breast cancer
    Yao, Sufei
    Shang, Chengzhang
    An, Gao
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    CANCER RESEARCH, 2023, 83 (08)
  • [4] Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial
    Bardia, A.
    Juric, D.
    Shimizu, T.
    Tolcher, A.
    Karim, R.
    Spira, A.
    Mukohara, T.
    Lisberg, A. E.
    Kogawa, T.
    Krop, I.
    Papadopoulos, K. P.
    Hamilton, E.
    Damodaran, S.
    Greenberg, J.
    Gu, W.
    Kobayashi, F.
    Guevara, F.
    Jikoh, T.
    Kawasaki, Y.
    Meric-Bernstam, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S60 - S60
  • [5] BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts
    Yao, Sufei
    Shang, Chengzhang
    An, Gao
    Guo, Chaoshe
    An, W. Frk
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [6] IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results
    Goldenberg, David M.
    Vahdat, Linda T.
    Starodub, Alexander N.
    Bardia, Aditya
    Chuang, Ellen
    Moroose, Rebecca L.
    Diamond, Jennifer R.
    Sharkey, Robert M.
    Maliakal, Pius P.
    Hamburger, Steven A.
    Ocean, Allyson J.
    CANCER RESEARCH, 2015, 75
  • [7] ESG401, a trophoblast cell-surface antigen 2 (TROP2) antibody drug conjugate (ADC), for the treatment of first-line metastatic triple negative breast cancer (mTNBC).
    Ma, Fei
    Qiu, Fuming
    Tong, Zhongsheng
    Shi, Yehui
    Yu, Guohua
    Wu, Xinhong
    Wang, Hong
    Wang, Jiani
    Yang, Hua
    Liu, Anwen
    Zhang, Yan
    Zheng, Hongmei
    Lan, Qiongyu
    Zhang, Yongqiang
    Cheng, Ying
    Zhou, Qing
    Xing, Xiaoyan
    Chen, Xiaomei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] ESG401, a novel Trop2 antibody-drug conjugate (ADC), and its efficacy evidence in HER2-negative metastatic breast cancer with brain metastases
    Ma, F.
    Qiu, F.
    Tong, Z.
    Wang, J.
    Shi, Y.
    Li, L.
    Yu, G.
    Shi, H.
    Wu, X.
    Liu, A.
    Zhang, Y.
    Wang, H.
    Cheng, Y.
    Yang, H.
    Li, H.
    Chang, J.
    Zhou, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S359 - S359
  • [9] Therapy of refractory/relapsed metastatic triple-negative breast cancer (TNBC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): Phase I/II clinical experience
    Bardia, Aditya
    Vahdat, Linda T.
    Diamond, Jennifer Robinson
    Starodub, Alexander
    Moroose, Rebecca L.
    Isakoff, Steven J.
    Ocean, Allyson J.
    Berlin, Jordan
    Messersmith, Wells A.
    Thomas, Sajeve Samuel
    Wilhelm, Francois
    Wegener, William A.
    Maliakal, Pius P.
    Sharkey, Robert M.
    Goldenberg, David M.
    Mayer, Ingrid A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer
    Huang, Wenpeng
    Li, Liming
    Zhou, Yuhan
    Yang, Qi
    Mixdorf, Jason C.
    Barnhart, Todd E.
    Hsu, Jessica C.
    Saladin, Rachel J.
    Liu, Chihao
    Rosenkrans, Zachary T.
    Engle, Jonathan W.
    Gao, Jianbo
    Kang, Lei
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
123